Global Cell Therapy CDMO Market Research Report 2026(Status and Outlook)
Cell Therapy CDMO is an outsourcing model that provides customized R&D and manufacturing services for cell therapy products, covering the entire process from early-stage process development to commercial production. Its services include cell collection, isolation, amplification, genetic engineering, quality testing, and GMP-compliant aseptic manufacturing and stability studies. Through specialized technology platforms and standardized production systems, Cell Therapy CDMO helps pharmaceutical companies and research institutions address the core challenges of scaling, consistency, and regulatory compliance for live cell products, significantly accelerating the translation process from laboratory to clinical applications and reducing R&D risks and costs.The cost structure of a Cell Therapy CDMO primarily includes investment in highly skilled R&D personnel, highly customized and expensive GMP production equipment and disposable consumables, as well as extremely stringent quality control and third-party testing fees. Its gross profit margin typically ranges from 35% to 55%, with the core drivers being the specialization and uniqueness of its technology platform, the efficiency of its production processes, and capacity utilization. Personalized therapies face cost pressures due to scale limitations and supply chain complexity, while generic therapies, if mass production and process standardization can be achieved, are more likely to achieve higher profitability.The global development of cell therapy CDMO presents a pattern of "three-pronged leadership and regional deepening." North America, as the absolute center of technology and market, boasts the most mature biotechnology ecosystem, leading CDMO companies, and an active capital market, dominating industry standards and innovation directions. Europe, with its strong research foundation and rigorous regulatory system, possesses formidable strength in advanced therapies, particularly excelling in academic translation and specialized technology platforms. The Asia-Pacific region is the core engine of global growth. Driven by strong policies, continuous capital investment, and huge clinical demand, China is rapidly upgrading from capacity absorption to technological innovation, while South Korea and Japan are also accelerating their expansion. Currently, supply chain resilience, regulatory differences, and the need for close clinical application are prompting global capacity layout to become more regionalized and decentralized, forming a multi-center collaborative network.
The global Cell Therapy CDMO market size was estimated at USD 2150.0 million in 2025 and is projected to grow at a compound annual growth rate (CAGR) of 8.10% during the forecast period.
This report offers a comprehensive and in-depth analysis of the global Cell Therapy CDMO market, covering all critical facets from a broad macroeconomic overview to detailed micro-level insights. It examines market size, competitive landscape, emerging development trends, niche segments, key drivers and challenges, as well as conducts SWOT and value chain analyses.
The insights provided enable readers to understand the competitive dynamics within the industry and formulate effective strategies to enhance profitability and market positioning. Additionally, the report presents a clear framework for evaluating the current status and future outlook of business organizations operating in this sector.
A significant focus of this report lies in the competitive landscape of the global Cell Therapy CDMO market. It offers detailed profiles of major players, including their market shares, performance metrics, product portfolios, and operational status. This enables stakeholders to identify leading competitors and gain a nuanced understanding of market rivalry and structure.
In summary, this report serves as an essential resource for industry participants, investors, researchers, consultants, and business strategists, as well as anyone planning to enter or expand their presence in the Cell Therapy CDMO market.
Global Cell Therapy CDMO Market: Market Segmentation Analysis
This research report provides a detailed segmentation of the market by region (country), key manufacturers, product type, and application. Market segmentation divides the overall market into distinct subsets based on factors such as product categories, end-user industries, geographic locations, and other relevant criteria.
A clear understanding of these market segments enables decision-makers to tailor their product development, sales, and marketing strategies more effectively to meet the unique needs of each segment. Leveraging market segmentation insights can significantly enhance targeted approaches, optimize resource allocation, and accelerate product innovation cycles by aligning offerings with the specific demands of diverse customer groups.
Key Company
Catalent
Lonza
Charles River
FUJIFILM Diosynth Biotechnologies
Exothera
Pharmaron
OBiO
AGC Biologics
Cytiva
ThermoGenesis
eXmoor Pharma
Advanced Therapies
Catalent Biologics
Patheon Pharma Services
Sartorius
Genezen
The Discovery Labs
Market Segmentation (by Type)
Autologous Cell Therapy CDMO
Allogeneic Cell Therapy CDMO
Viral Vector and Gene Editing CDMO
Market Segmentation (by Application)
Commercial
Academic Research
Others
Geographic Segmentation
North America (USA, Canada, Mexico)
Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
South America (Brazil, Argentina, Columbia, Rest of South America)
The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
Key Benefits of This Market Research:
Industry drivers, restraints, and opportunities covered in the study
Neutral perspective on the market performance
Recent industry trends and developments
Competitive landscape & strategies of key players
Potential & niche segments and regions exhibiting promising growth covered
Historical, current, and projected market size, in terms of value
In-depth analysis of the Cell Therapy CDMO Market
Overview of the regional outlook of the Cell Therapy CDMO Market:
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Cell Therapy CDMO Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 shares the main producing countries of Cell Therapy CDMO, their output value, profit level, regional supply, production capacity layout, etc. from the supply side.
Chapter 10 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 11 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 12 provides a quantitative analysis of the market size and development potential of each market segment in the next five years.
Chapter 13 is the main points and conclusions of the report.
Key Reasons to Buy this Report:
Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
This enables you to anticipate market changes to remain ahead of your competitors
You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
Provision of market value data for each segment and sub-segment
Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
Includes in-depth analysis of the market from various perspectives through Porter?s five forces analysis
Provides insight into the market through Value Chain
Market dynamics scenario, along with growth opportunities of the market in the years to come
6-month post-sales analyst support
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
The global Cell Therapy CDMO market size was estimated at USD 2150.0 million in 2025 and is projected to grow at a compound annual growth rate (CAGR) of 8.10% during the forecast period.
This report offers a comprehensive and in-depth analysis of the global Cell Therapy CDMO market, covering all critical facets from a broad macroeconomic overview to detailed micro-level insights. It examines market size, competitive landscape, emerging development trends, niche segments, key drivers and challenges, as well as conducts SWOT and value chain analyses.
The insights provided enable readers to understand the competitive dynamics within the industry and formulate effective strategies to enhance profitability and market positioning. Additionally, the report presents a clear framework for evaluating the current status and future outlook of business organizations operating in this sector.
A significant focus of this report lies in the competitive landscape of the global Cell Therapy CDMO market. It offers detailed profiles of major players, including their market shares, performance metrics, product portfolios, and operational status. This enables stakeholders to identify leading competitors and gain a nuanced understanding of market rivalry and structure.
In summary, this report serves as an essential resource for industry participants, investors, researchers, consultants, and business strategists, as well as anyone planning to enter or expand their presence in the Cell Therapy CDMO market.
Global Cell Therapy CDMO Market: Market Segmentation Analysis
This research report provides a detailed segmentation of the market by region (country), key manufacturers, product type, and application. Market segmentation divides the overall market into distinct subsets based on factors such as product categories, end-user industries, geographic locations, and other relevant criteria.
A clear understanding of these market segments enables decision-makers to tailor their product development, sales, and marketing strategies more effectively to meet the unique needs of each segment. Leveraging market segmentation insights can significantly enhance targeted approaches, optimize resource allocation, and accelerate product innovation cycles by aligning offerings with the specific demands of diverse customer groups.
Key Company
Catalent
Lonza
Charles River
FUJIFILM Diosynth Biotechnologies
Exothera
Pharmaron
OBiO
AGC Biologics
Cytiva
ThermoGenesis
eXmoor Pharma
Advanced Therapies
Catalent Biologics
Patheon Pharma Services
Sartorius
Genezen
The Discovery Labs
Market Segmentation (by Type)
Autologous Cell Therapy CDMO
Allogeneic Cell Therapy CDMO
Viral Vector and Gene Editing CDMO
Market Segmentation (by Application)
Commercial
Academic Research
Others
Geographic Segmentation
North America (USA, Canada, Mexico)
Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
South America (Brazil, Argentina, Columbia, Rest of South America)
The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
Key Benefits of This Market Research:
Industry drivers, restraints, and opportunities covered in the study
Neutral perspective on the market performance
Recent industry trends and developments
Competitive landscape & strategies of key players
Potential & niche segments and regions exhibiting promising growth covered
Historical, current, and projected market size, in terms of value
In-depth analysis of the Cell Therapy CDMO Market
Overview of the regional outlook of the Cell Therapy CDMO Market:
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Cell Therapy CDMO Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 shares the main producing countries of Cell Therapy CDMO, their output value, profit level, regional supply, production capacity layout, etc. from the supply side.
Chapter 10 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 11 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 12 provides a quantitative analysis of the market size and development potential of each market segment in the next five years.
Chapter 13 is the main points and conclusions of the report.
Key Reasons to Buy this Report:
Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
This enables you to anticipate market changes to remain ahead of your competitors
You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
Provision of market value data for each segment and sub-segment
Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
Includes in-depth analysis of the market from various perspectives through Porter?s five forces analysis
Provides insight into the market through Value Chain
Market dynamics scenario, along with growth opportunities of the market in the years to come
6-month post-sales analyst support
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
1 RESEARCH METHODOLOGY AND STATISTICAL SCOPE
1.1 Market Definition and Statistical Scope of Cell Therapy CDMO
1.2 Key Market Segments
1.2.1 Cell Therapy CDMO Segment by Type
1.2.2 Cell Therapy CDMO Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 CELL THERAPY CDMO MARKET OVERVIEW
2.1 Global Market Overview
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 CELL THERAPY CDMO MARKET COMPETITIVE LANDSCAPE
3.1 Company Assessment Quadrant
3.2 Global Cell Therapy CDMO Product Life Cycle
3.3 Global Cell Therapy CDMO Revenue Market Share by Company (2020-2025)
3.4 Cell Therapy CDMO Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.5 Headquarters, Areas Served, and Product Types of Major Players
3.6 Cell Therapy CDMO Market Competitive Situation and Trends
3.6.1 Cell Therapy CDMO Market Concentration Rate
3.6.2 Global 5 and 10 Largest Cell Therapy CDMO Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 CELL THERAPY CDMO VALUE CHAIN ANALYSIS
4.1 Cell Therapy CDMO Value Chain Analysis
4.2 Midstream Market Analysis
4.3 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF CELL THERAPY CDMO MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Industry News
5.4.1 New Product Developments
5.4.2 Mergers & Acquisitions
5.4.3 Expansions
5.4.4 Collaboration/Supply Contracts
5.5 PEST Analysis
5.5.1 Industry Policies Analysis
5.5.2 Economic Environment Analysis
5.5.3 Social Environment Analysis
5.5.4 Technological Environment Analysis
5.6 Global Cell Therapy CDMO Market Porter's Five Forces Analysis
6 CELL THERAPY CDMO MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Cell Therapy CDMO Market by Type (2020-2025)
6.3 Global Cell Therapy CDMO Market Size Growth Rate by Type (2021-2025)
7 CELL THERAPY CDMO MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Cell Therapy CDMO Market Size (M USD) by Application (2020-2025)
7.3 Global Cell Therapy CDMO Market Size Growth Rate by Application (2021-2025)
8 CELL THERAPY CDMO MARKET SEGMENTATION BY REGION
8.1 Global Cell Therapy CDMO Market Size by Region
8.1.1 Global Cell Therapy CDMO Market Size by Region
8.1.2 Global Cell Therapy CDMO Market Size Market Share by Region
8.2 North America
8.2.1 North America Cell Therapy CDMO Market Size by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Cell Therapy CDMO Market Size by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Spain
8.4 Asia Pacific
8.4.1 Asia Pacific Cell Therapy CDMO Market Size by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Cell Therapy CDMO Market Size by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Cell Therapy CDMO Market Size by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 KEY COMPANIES PROFILE
9.1 Catalent
9.1.1 Catalent Basic Information
9.1.2 Catalent Cell Therapy CDMO Product Overview
9.1.3 Catalent Cell Therapy CDMO Product Market Performance
9.1.4 Catalent SWOT Analysis
9.1.5 Catalent Business Overview
9.1.6 Catalent Recent Developments
9.2 Lonza
9.2.1 Lonza Basic Information
9.2.2 Lonza Cell Therapy CDMO Product Overview
9.2.3 Lonza Cell Therapy CDMO Product Market Performance
9.2.4 Lonza SWOT Analysis
9.2.5 Lonza Business Overview
9.2.6 Lonza Recent Developments
9.3 Charles River
9.3.1 Charles River Basic Information
9.3.2 Charles River Cell Therapy CDMO Product Overview
9.3.3 Charles River Cell Therapy CDMO Product Market Performance
9.3.4 Charles River SWOT Analysis
9.3.5 Charles River Business Overview
9.3.6 Charles River Recent Developments
9.4 FUJIFILM Diosynth Biotechnologies
9.4.1 FUJIFILM Diosynth Biotechnologies Basic Information
9.4.2 FUJIFILM Diosynth Biotechnologies Cell Therapy CDMO Product Overview
9.4.3 FUJIFILM Diosynth Biotechnologies Cell Therapy CDMO Product Market Performance
9.4.4 FUJIFILM Diosynth Biotechnologies Business Overview
9.4.5 FUJIFILM Diosynth Biotechnologies Recent Developments
9.5 Exothera
9.5.1 Exothera Basic Information
9.5.2 Exothera Cell Therapy CDMO Product Overview
9.5.3 Exothera Cell Therapy CDMO Product Market Performance
9.5.4 Exothera Business Overview
9.5.5 Exothera Recent Developments
9.6 Pharmaron
9.6.1 Pharmaron Basic Information
9.6.2 Pharmaron Cell Therapy CDMO Product Overview
9.6.3 Pharmaron Cell Therapy CDMO Product Market Performance
9.6.4 Pharmaron Business Overview
9.6.5 Pharmaron Recent Developments
9.7 OBiO
9.7.1 OBiO Basic Information
9.7.2 OBiO Cell Therapy CDMO Product Overview
9.7.3 OBiO Cell Therapy CDMO Product Market Performance
9.7.4 OBiO Business Overview
9.7.5 OBiO Recent Developments
9.8 AGC Biologics
9.8.1 AGC Biologics Basic Information
9.8.2 AGC Biologics Cell Therapy CDMO Product Overview
9.8.3 AGC Biologics Cell Therapy CDMO Product Market Performance
9.8.4 AGC Biologics Business Overview
9.8.5 AGC Biologics Recent Developments
9.9 Cytiva
9.9.1 Cytiva Basic Information
9.9.2 Cytiva Cell Therapy CDMO Product Overview
9.9.3 Cytiva Cell Therapy CDMO Product Market Performance
9.9.4 Cytiva Business Overview
9.9.5 Cytiva Recent Developments
9.10 ThermoGenesis
9.10.1 ThermoGenesis Basic Information
9.10.2 ThermoGenesis Cell Therapy CDMO Product Overview
9.10.3 ThermoGenesis Cell Therapy CDMO Product Market Performance
9.10.4 ThermoGenesis Business Overview
9.10.5 ThermoGenesis Recent Developments
9.11 eXmoor Pharma
9.11.1 eXmoor Pharma Basic Information
9.11.2 eXmoor Pharma Cell Therapy CDMO Product Overview
9.11.3 eXmoor Pharma Cell Therapy CDMO Product Market Performance
9.11.4 eXmoor Pharma Business Overview
9.11.5 eXmoor Pharma Recent Developments
9.12 Advanced Therapies
9.12.1 Advanced Therapies Basic Information
9.12.2 Advanced Therapies Cell Therapy CDMO Product Overview
9.12.3 Advanced Therapies Cell Therapy CDMO Product Market Performance
9.12.4 Advanced Therapies Business Overview
9.12.5 Advanced Therapies Recent Developments
9.13 Catalent Biologics
9.13.1 Catalent Biologics Basic Information
9.13.2 Catalent Biologics Cell Therapy CDMO Product Overview
9.13.3 Catalent Biologics Cell Therapy CDMO Product Market Performance
9.13.4 Catalent Biologics Business Overview
9.13.5 Catalent Biologics Recent Developments
9.14 Patheon Pharma Services
9.14.1 Patheon Pharma Services Basic Information
9.14.2 Patheon Pharma Services Cell Therapy CDMO Product Overview
9.14.3 Patheon Pharma Services Cell Therapy CDMO Product Market Performance
9.14.4 Patheon Pharma Services Business Overview
9.14.5 Patheon Pharma Services Recent Developments
9.15 Sartorius
9.15.1 Sartorius Basic Information
9.15.2 Sartorius Cell Therapy CDMO Product Overview
9.15.3 Sartorius Cell Therapy CDMO Product Market Performance
9.15.4 Sartorius Business Overview
9.15.5 Sartorius Recent Developments
9.16 Genezen
9.16.1 Genezen Basic Information
9.16.2 Genezen Cell Therapy CDMO Product Overview
9.16.3 Genezen Cell Therapy CDMO Product Market Performance
9.16.4 Genezen Business Overview
9.16.5 Genezen Recent Developments
9.17 The Discovery Labs
9.17.1 The Discovery Labs Basic Information
9.17.2 The Discovery Labs Cell Therapy CDMO Product Overview
9.17.3 The Discovery Labs Cell Therapy CDMO Product Market Performance
9.17.4 The Discovery Labs Business Overview
9.17.5 The Discovery Labs Recent Developments
10 CELL THERAPY CDMO MARKET FORECAST BY REGION
10.1 Global Cell Therapy CDMO Market Size Forecast
10.2 Global Cell Therapy CDMO Market Forecast by Region
10.2.1 North America Market Size Forecast by Country
10.2.2 Europe Cell Therapy CDMO Market Size Forecast by Country
10.2.3 Asia Pacific Cell Therapy CDMO Market Size Forecast by Region
10.2.4 South America Cell Therapy CDMO Market Size Forecast by Country
10.2.5 Middle East and Africa Forecasted Sales of Cell Therapy CDMO by Country
11 FORECAST MARKET BY TYPE AND BY APPLICATION (2026-2035)
11.1 Global Cell Therapy CDMO Market Forecast by Type (2026-2035)
11.1.1 Global Cell Therapy CDMO Market Size Forecast by Type (2026-2035)
11.2 Global Cell Therapy CDMO Market Forecast by Application (2026-2035)
11.2.1 Global Cell Therapy CDMO Market Size (M USD) Forecast by Application (2026-2035)
12 CONCLUSION AND KEY FINDINGS
1.1 Market Definition and Statistical Scope of Cell Therapy CDMO
1.2 Key Market Segments
1.2.1 Cell Therapy CDMO Segment by Type
1.2.2 Cell Therapy CDMO Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 CELL THERAPY CDMO MARKET OVERVIEW
2.1 Global Market Overview
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 CELL THERAPY CDMO MARKET COMPETITIVE LANDSCAPE
3.1 Company Assessment Quadrant
3.2 Global Cell Therapy CDMO Product Life Cycle
3.3 Global Cell Therapy CDMO Revenue Market Share by Company (2020-2025)
3.4 Cell Therapy CDMO Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.5 Headquarters, Areas Served, and Product Types of Major Players
3.6 Cell Therapy CDMO Market Competitive Situation and Trends
3.6.1 Cell Therapy CDMO Market Concentration Rate
3.6.2 Global 5 and 10 Largest Cell Therapy CDMO Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 CELL THERAPY CDMO VALUE CHAIN ANALYSIS
4.1 Cell Therapy CDMO Value Chain Analysis
4.2 Midstream Market Analysis
4.3 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF CELL THERAPY CDMO MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Industry News
5.4.1 New Product Developments
5.4.2 Mergers & Acquisitions
5.4.3 Expansions
5.4.4 Collaboration/Supply Contracts
5.5 PEST Analysis
5.5.1 Industry Policies Analysis
5.5.2 Economic Environment Analysis
5.5.3 Social Environment Analysis
5.5.4 Technological Environment Analysis
5.6 Global Cell Therapy CDMO Market Porter's Five Forces Analysis
6 CELL THERAPY CDMO MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Cell Therapy CDMO Market by Type (2020-2025)
6.3 Global Cell Therapy CDMO Market Size Growth Rate by Type (2021-2025)
7 CELL THERAPY CDMO MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Cell Therapy CDMO Market Size (M USD) by Application (2020-2025)
7.3 Global Cell Therapy CDMO Market Size Growth Rate by Application (2021-2025)
8 CELL THERAPY CDMO MARKET SEGMENTATION BY REGION
8.1 Global Cell Therapy CDMO Market Size by Region
8.1.1 Global Cell Therapy CDMO Market Size by Region
8.1.2 Global Cell Therapy CDMO Market Size Market Share by Region
8.2 North America
8.2.1 North America Cell Therapy CDMO Market Size by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Cell Therapy CDMO Market Size by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Spain
8.4 Asia Pacific
8.4.1 Asia Pacific Cell Therapy CDMO Market Size by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Cell Therapy CDMO Market Size by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Cell Therapy CDMO Market Size by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 KEY COMPANIES PROFILE
9.1 Catalent
9.1.1 Catalent Basic Information
9.1.2 Catalent Cell Therapy CDMO Product Overview
9.1.3 Catalent Cell Therapy CDMO Product Market Performance
9.1.4 Catalent SWOT Analysis
9.1.5 Catalent Business Overview
9.1.6 Catalent Recent Developments
9.2 Lonza
9.2.1 Lonza Basic Information
9.2.2 Lonza Cell Therapy CDMO Product Overview
9.2.3 Lonza Cell Therapy CDMO Product Market Performance
9.2.4 Lonza SWOT Analysis
9.2.5 Lonza Business Overview
9.2.6 Lonza Recent Developments
9.3 Charles River
9.3.1 Charles River Basic Information
9.3.2 Charles River Cell Therapy CDMO Product Overview
9.3.3 Charles River Cell Therapy CDMO Product Market Performance
9.3.4 Charles River SWOT Analysis
9.3.5 Charles River Business Overview
9.3.6 Charles River Recent Developments
9.4 FUJIFILM Diosynth Biotechnologies
9.4.1 FUJIFILM Diosynth Biotechnologies Basic Information
9.4.2 FUJIFILM Diosynth Biotechnologies Cell Therapy CDMO Product Overview
9.4.3 FUJIFILM Diosynth Biotechnologies Cell Therapy CDMO Product Market Performance
9.4.4 FUJIFILM Diosynth Biotechnologies Business Overview
9.4.5 FUJIFILM Diosynth Biotechnologies Recent Developments
9.5 Exothera
9.5.1 Exothera Basic Information
9.5.2 Exothera Cell Therapy CDMO Product Overview
9.5.3 Exothera Cell Therapy CDMO Product Market Performance
9.5.4 Exothera Business Overview
9.5.5 Exothera Recent Developments
9.6 Pharmaron
9.6.1 Pharmaron Basic Information
9.6.2 Pharmaron Cell Therapy CDMO Product Overview
9.6.3 Pharmaron Cell Therapy CDMO Product Market Performance
9.6.4 Pharmaron Business Overview
9.6.5 Pharmaron Recent Developments
9.7 OBiO
9.7.1 OBiO Basic Information
9.7.2 OBiO Cell Therapy CDMO Product Overview
9.7.3 OBiO Cell Therapy CDMO Product Market Performance
9.7.4 OBiO Business Overview
9.7.5 OBiO Recent Developments
9.8 AGC Biologics
9.8.1 AGC Biologics Basic Information
9.8.2 AGC Biologics Cell Therapy CDMO Product Overview
9.8.3 AGC Biologics Cell Therapy CDMO Product Market Performance
9.8.4 AGC Biologics Business Overview
9.8.5 AGC Biologics Recent Developments
9.9 Cytiva
9.9.1 Cytiva Basic Information
9.9.2 Cytiva Cell Therapy CDMO Product Overview
9.9.3 Cytiva Cell Therapy CDMO Product Market Performance
9.9.4 Cytiva Business Overview
9.9.5 Cytiva Recent Developments
9.10 ThermoGenesis
9.10.1 ThermoGenesis Basic Information
9.10.2 ThermoGenesis Cell Therapy CDMO Product Overview
9.10.3 ThermoGenesis Cell Therapy CDMO Product Market Performance
9.10.4 ThermoGenesis Business Overview
9.10.5 ThermoGenesis Recent Developments
9.11 eXmoor Pharma
9.11.1 eXmoor Pharma Basic Information
9.11.2 eXmoor Pharma Cell Therapy CDMO Product Overview
9.11.3 eXmoor Pharma Cell Therapy CDMO Product Market Performance
9.11.4 eXmoor Pharma Business Overview
9.11.5 eXmoor Pharma Recent Developments
9.12 Advanced Therapies
9.12.1 Advanced Therapies Basic Information
9.12.2 Advanced Therapies Cell Therapy CDMO Product Overview
9.12.3 Advanced Therapies Cell Therapy CDMO Product Market Performance
9.12.4 Advanced Therapies Business Overview
9.12.5 Advanced Therapies Recent Developments
9.13 Catalent Biologics
9.13.1 Catalent Biologics Basic Information
9.13.2 Catalent Biologics Cell Therapy CDMO Product Overview
9.13.3 Catalent Biologics Cell Therapy CDMO Product Market Performance
9.13.4 Catalent Biologics Business Overview
9.13.5 Catalent Biologics Recent Developments
9.14 Patheon Pharma Services
9.14.1 Patheon Pharma Services Basic Information
9.14.2 Patheon Pharma Services Cell Therapy CDMO Product Overview
9.14.3 Patheon Pharma Services Cell Therapy CDMO Product Market Performance
9.14.4 Patheon Pharma Services Business Overview
9.14.5 Patheon Pharma Services Recent Developments
9.15 Sartorius
9.15.1 Sartorius Basic Information
9.15.2 Sartorius Cell Therapy CDMO Product Overview
9.15.3 Sartorius Cell Therapy CDMO Product Market Performance
9.15.4 Sartorius Business Overview
9.15.5 Sartorius Recent Developments
9.16 Genezen
9.16.1 Genezen Basic Information
9.16.2 Genezen Cell Therapy CDMO Product Overview
9.16.3 Genezen Cell Therapy CDMO Product Market Performance
9.16.4 Genezen Business Overview
9.16.5 Genezen Recent Developments
9.17 The Discovery Labs
9.17.1 The Discovery Labs Basic Information
9.17.2 The Discovery Labs Cell Therapy CDMO Product Overview
9.17.3 The Discovery Labs Cell Therapy CDMO Product Market Performance
9.17.4 The Discovery Labs Business Overview
9.17.5 The Discovery Labs Recent Developments
10 CELL THERAPY CDMO MARKET FORECAST BY REGION
10.1 Global Cell Therapy CDMO Market Size Forecast
10.2 Global Cell Therapy CDMO Market Forecast by Region
10.2.1 North America Market Size Forecast by Country
10.2.2 Europe Cell Therapy CDMO Market Size Forecast by Country
10.2.3 Asia Pacific Cell Therapy CDMO Market Size Forecast by Region
10.2.4 South America Cell Therapy CDMO Market Size Forecast by Country
10.2.5 Middle East and Africa Forecasted Sales of Cell Therapy CDMO by Country
11 FORECAST MARKET BY TYPE AND BY APPLICATION (2026-2035)
11.1 Global Cell Therapy CDMO Market Forecast by Type (2026-2035)
11.1.1 Global Cell Therapy CDMO Market Size Forecast by Type (2026-2035)
11.2 Global Cell Therapy CDMO Market Forecast by Application (2026-2035)
11.2.1 Global Cell Therapy CDMO Market Size (M USD) Forecast by Application (2026-2035)
12 CONCLUSION AND KEY FINDINGS
LIST OF TABLES
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Global Cell Therapy CDMO Market Size by Type (M USD)
Table 4. Global Cell Therapy CDMO Market Size by Application
Table 5. Cell Therapy CDMO Market Size Comparison by Region (M USD)
Table 6. Global Cell Therapy CDMO Revenue (M USD) by Company (2020-2025)
Table 7. Global Cell Therapy CDMO Revenue Share by Company (2020-2025)
Table 8. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Cell Therapy CDMO as of 2025)
Table 9. Headquarters, Areas Served, and Product Types of Major Players
Table 10. Product Type of Major Players
Table 11. Global Cell Therapy CDMO Company Market Concentration Ratio (CR5 and HHI)
Table 12. Mergers & Acquisitions, Expansion Plans
Table 13. Midstream Market Analysis
Table 14. Downstream Customer Analysis
Table 15. Key Development Trends
Table 16. Driving Factors
Table 17. Cell Therapy CDMO Market Challenges
Table 18. Goldman Sachs' forecast real GDP growth rate for 2024-2026
Table 19. S&P Global ' Forecast Real GDP Growth Rate For 2024-2027
Table 20. World Bank ' Forecast Real GDP Growth Rate For 2024-2026
Table 21. Global Cell Therapy CDMO Market Size by Type (M USD)
Table 22. Global Cell Therapy CDMO Market Size (M USD) by Type (2020-2025)
Table 23. Global Cell Therapy CDMO Market Share by Type (2020-2025)
Table 24. Global Cell Therapy CDMO Market Size Growth Rate by Type (2021-2025)
Table 25. Global Cell Therapy CDMO Market Size by Application
Table 26. Global Cell Therapy CDMO Market Size by Application (2020-2025) & (M USD)
Table 27. Global Cell Therapy CDMO Market Share by Application (2020-2025)
Table 28. Global Cell Therapy CDMO Market Size Growth Rate by Application (2021-2025)
Table 29. Global Cell Therapy CDMO Market Size by Region (2020-2025) & (M USD)
Table 30. Global Cell Therapy CDMO Market Size Market Share by Region (2020-2025)
Table 31. North America Cell Therapy CDMO Market Size by Country (2020-2025) & (M USD)
Table 32. Europe Cell Therapy CDMO Market Size by Country (2020-2025) & (M USD)
Table 33. Asia Pacific Cell Therapy CDMO Market Size by Region (2020-2025) & (M USD)
Table 34. South America Cell Therapy CDMO Market Size by Country (2020-2025) & (M USD)
Table 35. Middle East and Africa Cell Therapy CDMO Market Size by Region (2020-2025) & (M USD)
Table 36. Catalent Basic Information
Table 37. Catalent Cell Therapy CDMO Product Overview
Table 38. Catalent Cell Therapy CDMO Revenue (M USD) and Gross Margin (2020-2025)
Table 39. Catalent SWOT Analysis
Table 40. Catalent Business Overview
Table 41. Catalent Recent Developments
Table 42. Lonza Basic Information
Table 43. Lonza Cell Therapy CDMO Product Overview
Table 44. Lonza Cell Therapy CDMO Revenue (M USD) and Gross Margin (2020-2025)
Table 45. Lonza SWOT Analysis
Table 46. Lonza Business Overview
Table 47. Lonza Recent Developments
Table 48. Charles River Basic Information
Table 49. Charles River Cell Therapy CDMO Product Overview
Table 50. Charles River Cell Therapy CDMO Revenue (M USD) and Gross Margin (2020-2025)
Table 51. Charles River SWOT Analysis
Table 52. Charles River Business Overview
Table 53. Charles River Recent Developments
Table 54. FUJIFILM Diosynth Biotechnologies Basic Information
Table 55. FUJIFILM Diosynth Biotechnologies Cell Therapy CDMO Product Overview
Table 56. FUJIFILM Diosynth Biotechnologies Cell Therapy CDMO Revenue (M USD) and Gross Margin (2020-2025)
Table 57. FUJIFILM Diosynth Biotechnologies Business Overview
Table 58. FUJIFILM Diosynth Biotechnologies Recent Developments
Table 59. Exothera Basic Information
Table 60. Exothera Cell Therapy CDMO Product Overview
Table 61. Exothera Cell Therapy CDMO Revenue (M USD) and Gross Margin (2020-2025)
Table 62. Exothera Business Overview
Table 63. Exothera Recent Developments
Table 64. Pharmaron Basic Information
Table 65. Pharmaron Cell Therapy CDMO Product Overview
Table 66. Pharmaron Cell Therapy CDMO Revenue (M USD) and Gross Margin (2020-2025)
Table 67. Pharmaron Business Overview
Table 68. Pharmaron Recent Developments
Table 69. OBiO Basic Information
Table 70. OBiO Cell Therapy CDMO Product Overview
Table 71. OBiO Cell Therapy CDMO Revenue (M USD) and Gross Margin (2020-2025)
Table 72. OBiO Business Overview
Table 73. OBiO Recent Developments
Table 74. AGC Biologics Basic Information
Table 75. AGC Biologics Cell Therapy CDMO Product Overview
Table 76. AGC Biologics Cell Therapy CDMO Revenue (M USD) and Gross Margin (2020-2025)
Table 77. AGC Biologics Business Overview
Table 78. AGC Biologics Recent Developments
Table 79. Cytiva Basic Information
Table 80. Cytiva Cell Therapy CDMO Product Overview
Table 81. Cytiva Cell Therapy CDMO Revenue (M USD) and Gross Margin (2020-2025)
Table 82. Cytiva Business Overview
Table 83. Cytiva Recent Developments
Table 84. ThermoGenesis Basic Information
Table 85. ThermoGenesis Cell Therapy CDMO Product Overview
Table 86. ThermoGenesis Cell Therapy CDMO Revenue (M USD) and Gross Margin (2020-2025)
Table 87. ThermoGenesis Business Overview
Table 88. ThermoGenesis Recent Developments
Table 89. eXmoor Pharma Basic Information
Table 90. eXmoor Pharma Cell Therapy CDMO Product Overview
Table 91. eXmoor Pharma Cell Therapy CDMO Revenue (M USD) and Gross Margin (2020-2025)
Table 92. eXmoor Pharma Business Overview
Table 93. eXmoor Pharma Recent Developments
Table 94. Advanced Therapies Basic Information
Table 95. Advanced Therapies Cell Therapy CDMO Product Overview
Table 96. Advanced Therapies Cell Therapy CDMO Revenue (M USD) and Gross Margin (2020-2025)
Table 97. Advanced Therapies Business Overview
Table 98. Advanced Therapies Recent Developments
Table 99. Catalent Biologics Basic Information
Table 100. Catalent Biologics Cell Therapy CDMO Product Overview
Table 101. Catalent Biologics Cell Therapy CDMO Revenue (M USD) and Gross Margin (2020-2025)
Table 102. Catalent Biologics Business Overview
Table 103. Catalent Biologics Recent Developments
Table 104. Patheon Pharma Services Basic Information
Table 105. Patheon Pharma Services Cell Therapy CDMO Product Overview
Table 106. Patheon Pharma Services Cell Therapy CDMO Revenue (M USD) and Gross Margin (2020-2025)
Table 107. Patheon Pharma Services Business Overview
Table 108. Patheon Pharma Services Recent Developments
Table 109. Sartorius Basic Information
Table 110. Sartorius Cell Therapy CDMO Product Overview
Table 111. Sartorius Cell Therapy CDMO Revenue (M USD) and Gross Margin (2020-2025)
Table 112. Sartorius Business Overview
Table 113. Sartorius Recent Developments
Table 114. Genezen Basic Information
Table 115. Genezen Cell Therapy CDMO Product Overview
Table 116. Genezen Cell Therapy CDMO Revenue (M USD) and Gross Margin (2020-2025)
Table 117. Genezen Business Overview
Table 118. Genezen Recent Developments
Table 119. The Discovery Labs Basic Information
Table 120. The Discovery Labs Cell Therapy CDMO Product Overview
Table 121. The Discovery Labs Cell Therapy CDMO Revenue (M USD) and Gross Margin (2020-2025)
Table 122. The Discovery Labs Business Overview
Table 123. The Discovery Labs Recent Developments
Table 124. Global Cell Therapy CDMO Market Size Forecast by Region (2026-2035) & (M USD)
Table 125. North America Cell Therapy CDMO Market Size Forecast by Country (2026-2035) & (M USD)
Table 126. Europe Cell Therapy CDMO Market Size Forecast by Country (2026-2035) & (M USD)
Table 127. Asia Pacific Cell Therapy CDMO Market Size Forecast by Region (2026-2035) & (M USD)
Table 128. South America Cell Therapy CDMO Market Size Forecast by Country (2026-2035) & (M USD)
Table 129. Middle East and Africa Cell Therapy CDMO Market Size Forecast by Country (2026-2035) & (M USD)
Table 130. Global Cell Therapy CDMO Market Size Forecast by Type (2026-2035) & (M USD)
Table 131. Global Cell Therapy CDMO Market Size Forecast by Application (2026-2035) & (M USD)
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Global Cell Therapy CDMO Market Size by Type (M USD)
Table 4. Global Cell Therapy CDMO Market Size by Application
Table 5. Cell Therapy CDMO Market Size Comparison by Region (M USD)
Table 6. Global Cell Therapy CDMO Revenue (M USD) by Company (2020-2025)
Table 7. Global Cell Therapy CDMO Revenue Share by Company (2020-2025)
Table 8. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Cell Therapy CDMO as of 2025)
Table 9. Headquarters, Areas Served, and Product Types of Major Players
Table 10. Product Type of Major Players
Table 11. Global Cell Therapy CDMO Company Market Concentration Ratio (CR5 and HHI)
Table 12. Mergers & Acquisitions, Expansion Plans
Table 13. Midstream Market Analysis
Table 14. Downstream Customer Analysis
Table 15. Key Development Trends
Table 16. Driving Factors
Table 17. Cell Therapy CDMO Market Challenges
Table 18. Goldman Sachs' forecast real GDP growth rate for 2024-2026
Table 19. S&P Global ' Forecast Real GDP Growth Rate For 2024-2027
Table 20. World Bank ' Forecast Real GDP Growth Rate For 2024-2026
Table 21. Global Cell Therapy CDMO Market Size by Type (M USD)
Table 22. Global Cell Therapy CDMO Market Size (M USD) by Type (2020-2025)
Table 23. Global Cell Therapy CDMO Market Share by Type (2020-2025)
Table 24. Global Cell Therapy CDMO Market Size Growth Rate by Type (2021-2025)
Table 25. Global Cell Therapy CDMO Market Size by Application
Table 26. Global Cell Therapy CDMO Market Size by Application (2020-2025) & (M USD)
Table 27. Global Cell Therapy CDMO Market Share by Application (2020-2025)
Table 28. Global Cell Therapy CDMO Market Size Growth Rate by Application (2021-2025)
Table 29. Global Cell Therapy CDMO Market Size by Region (2020-2025) & (M USD)
Table 30. Global Cell Therapy CDMO Market Size Market Share by Region (2020-2025)
Table 31. North America Cell Therapy CDMO Market Size by Country (2020-2025) & (M USD)
Table 32. Europe Cell Therapy CDMO Market Size by Country (2020-2025) & (M USD)
Table 33. Asia Pacific Cell Therapy CDMO Market Size by Region (2020-2025) & (M USD)
Table 34. South America Cell Therapy CDMO Market Size by Country (2020-2025) & (M USD)
Table 35. Middle East and Africa Cell Therapy CDMO Market Size by Region (2020-2025) & (M USD)
Table 36. Catalent Basic Information
Table 37. Catalent Cell Therapy CDMO Product Overview
Table 38. Catalent Cell Therapy CDMO Revenue (M USD) and Gross Margin (2020-2025)
Table 39. Catalent SWOT Analysis
Table 40. Catalent Business Overview
Table 41. Catalent Recent Developments
Table 42. Lonza Basic Information
Table 43. Lonza Cell Therapy CDMO Product Overview
Table 44. Lonza Cell Therapy CDMO Revenue (M USD) and Gross Margin (2020-2025)
Table 45. Lonza SWOT Analysis
Table 46. Lonza Business Overview
Table 47. Lonza Recent Developments
Table 48. Charles River Basic Information
Table 49. Charles River Cell Therapy CDMO Product Overview
Table 50. Charles River Cell Therapy CDMO Revenue (M USD) and Gross Margin (2020-2025)
Table 51. Charles River SWOT Analysis
Table 52. Charles River Business Overview
Table 53. Charles River Recent Developments
Table 54. FUJIFILM Diosynth Biotechnologies Basic Information
Table 55. FUJIFILM Diosynth Biotechnologies Cell Therapy CDMO Product Overview
Table 56. FUJIFILM Diosynth Biotechnologies Cell Therapy CDMO Revenue (M USD) and Gross Margin (2020-2025)
Table 57. FUJIFILM Diosynth Biotechnologies Business Overview
Table 58. FUJIFILM Diosynth Biotechnologies Recent Developments
Table 59. Exothera Basic Information
Table 60. Exothera Cell Therapy CDMO Product Overview
Table 61. Exothera Cell Therapy CDMO Revenue (M USD) and Gross Margin (2020-2025)
Table 62. Exothera Business Overview
Table 63. Exothera Recent Developments
Table 64. Pharmaron Basic Information
Table 65. Pharmaron Cell Therapy CDMO Product Overview
Table 66. Pharmaron Cell Therapy CDMO Revenue (M USD) and Gross Margin (2020-2025)
Table 67. Pharmaron Business Overview
Table 68. Pharmaron Recent Developments
Table 69. OBiO Basic Information
Table 70. OBiO Cell Therapy CDMO Product Overview
Table 71. OBiO Cell Therapy CDMO Revenue (M USD) and Gross Margin (2020-2025)
Table 72. OBiO Business Overview
Table 73. OBiO Recent Developments
Table 74. AGC Biologics Basic Information
Table 75. AGC Biologics Cell Therapy CDMO Product Overview
Table 76. AGC Biologics Cell Therapy CDMO Revenue (M USD) and Gross Margin (2020-2025)
Table 77. AGC Biologics Business Overview
Table 78. AGC Biologics Recent Developments
Table 79. Cytiva Basic Information
Table 80. Cytiva Cell Therapy CDMO Product Overview
Table 81. Cytiva Cell Therapy CDMO Revenue (M USD) and Gross Margin (2020-2025)
Table 82. Cytiva Business Overview
Table 83. Cytiva Recent Developments
Table 84. ThermoGenesis Basic Information
Table 85. ThermoGenesis Cell Therapy CDMO Product Overview
Table 86. ThermoGenesis Cell Therapy CDMO Revenue (M USD) and Gross Margin (2020-2025)
Table 87. ThermoGenesis Business Overview
Table 88. ThermoGenesis Recent Developments
Table 89. eXmoor Pharma Basic Information
Table 90. eXmoor Pharma Cell Therapy CDMO Product Overview
Table 91. eXmoor Pharma Cell Therapy CDMO Revenue (M USD) and Gross Margin (2020-2025)
Table 92. eXmoor Pharma Business Overview
Table 93. eXmoor Pharma Recent Developments
Table 94. Advanced Therapies Basic Information
Table 95. Advanced Therapies Cell Therapy CDMO Product Overview
Table 96. Advanced Therapies Cell Therapy CDMO Revenue (M USD) and Gross Margin (2020-2025)
Table 97. Advanced Therapies Business Overview
Table 98. Advanced Therapies Recent Developments
Table 99. Catalent Biologics Basic Information
Table 100. Catalent Biologics Cell Therapy CDMO Product Overview
Table 101. Catalent Biologics Cell Therapy CDMO Revenue (M USD) and Gross Margin (2020-2025)
Table 102. Catalent Biologics Business Overview
Table 103. Catalent Biologics Recent Developments
Table 104. Patheon Pharma Services Basic Information
Table 105. Patheon Pharma Services Cell Therapy CDMO Product Overview
Table 106. Patheon Pharma Services Cell Therapy CDMO Revenue (M USD) and Gross Margin (2020-2025)
Table 107. Patheon Pharma Services Business Overview
Table 108. Patheon Pharma Services Recent Developments
Table 109. Sartorius Basic Information
Table 110. Sartorius Cell Therapy CDMO Product Overview
Table 111. Sartorius Cell Therapy CDMO Revenue (M USD) and Gross Margin (2020-2025)
Table 112. Sartorius Business Overview
Table 113. Sartorius Recent Developments
Table 114. Genezen Basic Information
Table 115. Genezen Cell Therapy CDMO Product Overview
Table 116. Genezen Cell Therapy CDMO Revenue (M USD) and Gross Margin (2020-2025)
Table 117. Genezen Business Overview
Table 118. Genezen Recent Developments
Table 119. The Discovery Labs Basic Information
Table 120. The Discovery Labs Cell Therapy CDMO Product Overview
Table 121. The Discovery Labs Cell Therapy CDMO Revenue (M USD) and Gross Margin (2020-2025)
Table 122. The Discovery Labs Business Overview
Table 123. The Discovery Labs Recent Developments
Table 124. Global Cell Therapy CDMO Market Size Forecast by Region (2026-2035) & (M USD)
Table 125. North America Cell Therapy CDMO Market Size Forecast by Country (2026-2035) & (M USD)
Table 126. Europe Cell Therapy CDMO Market Size Forecast by Country (2026-2035) & (M USD)
Table 127. Asia Pacific Cell Therapy CDMO Market Size Forecast by Region (2026-2035) & (M USD)
Table 128. South America Cell Therapy CDMO Market Size Forecast by Country (2026-2035) & (M USD)
Table 129. Middle East and Africa Cell Therapy CDMO Market Size Forecast by Country (2026-2035) & (M USD)
Table 130. Global Cell Therapy CDMO Market Size Forecast by Type (2026-2035) & (M USD)
Table 131. Global Cell Therapy CDMO Market Size Forecast by Application (2026-2035) & (M USD)
LIST OF FIGURES
Figure 1. Industry Chain of Cell Therapy CDMO
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Cell Therapy CDMO Market Size (M USD), 2025-2035
Figure 5. Global Cell Therapy CDMO Market Size (M USD) (2020-2035)
Figure 6. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 8. Evaluation Matrix of Regional Market Development Potential
Figure 9. Cell Therapy CDMO Market Size by Country (M USD)
Figure 10. Company Assessment Quadrant
Figure 11. Global Cell Therapy CDMO Product Life Cycle
Figure 12. Global Cell Therapy CDMO Revenue Share by Company in 2025
Figure 13. Cell Therapy CDMO Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2025
Figure 14. The Global 5 and 10 Largest Players: Market Share by Cell Therapy CDMO Revenue in 2025
Figure 15. Value Chain Map of Cell Therapy CDMO
Figure 16. Global Cell Therapy CDMO Market PEST Analysis
Figure 17. Global Cell Therapy CDMO Market Porter's Five Forces Analysis
Figure 18. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 19. Global Cell Therapy CDMO Market Share by Type
Figure 20. Market Share of Cell Therapy CDMO by Type (2020-2025)
Figure 21. Global Cell Therapy CDMO Market Size Growth Rate by Type (2021-2025)
Figure 22. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 23. Global Cell Therapy CDMO Market Share by Application
Figure 24. Global Cell Therapy CDMO Market Share by Application (2020-2025)
Figure 25. Global Cell Therapy CDMO Market Share by Application in 2024
Figure 26. Global Cell Therapy CDMO Market Size Growth Rate by Application (2021-2025)
Figure 27. Global Cell Therapy CDMO Market Size Market Share by Region (2020-2025)
Figure 28. North America Cell Therapy CDMO Market Size and Growth Rate (2020-2025) & (M USD)
Figure 29. North America Cell Therapy CDMO Market Size Market Share by Country in 2024
Figure 30. U.S. Cell Therapy CDMO Market Size and Growth Rate (2020-2025) & (M USD)
Figure 31. Canada Cell Therapy CDMO Market Size (M USD) and Growth Rate (2020-2025)
Figure 32. Mexico Cell Therapy CDMO Market Size (M USD) and Growth Rate (2020-2025)
Figure 33. Europe Cell Therapy CDMO Market Size and Growth Rate (2020-2025) & (M USD)
Figure 34. Europe Cell Therapy CDMO Market Share by Country in 2024
Figure 35. Germany Cell Therapy CDMO Market Size and Growth Rate (2020-2025) & (M USD)
Figure 36. France Cell Therapy CDMO Market Size and Growth Rate (2020-2025) & (M USD)
Figure 37. U.K. Cell Therapy CDMO Market Size and Growth Rate (2020-2025) & (M USD)
Figure 38. Italy Cell Therapy CDMO Market Size and Growth Rate (2020-2025) & (M USD)
Figure 39. Spain Cell Therapy CDMO Market Size and Growth Rate (2020-2025) & (M USD)
Figure 40. Asia Pacific Cell Therapy CDMO Market Size and Growth Rate (M USD)
Figure 41. Asia Pacific Cell Therapy CDMO Market Size Market Share by Region in 2024
Figure 42. China Cell Therapy CDMO Market Size and Growth Rate (2020-2025) & (M USD)
Figure 43. Japan Cell Therapy CDMO Market Size and Growth Rate (2020-2025) & (M USD)
Figure 44. South Korea Cell Therapy CDMO Market Size and Growth Rate (2020-2025) & (M USD)
Figure 45. India Cell Therapy CDMO Market Size and Growth Rate (2020-2025) & (M USD)
Figure 46. Southeast Asia Cell Therapy CDMO Market Size and Growth Rate (2020-2025) & (M USD)
Figure 47. South America Cell Therapy CDMO Market Size and Growth Rate (M USD)
Figure 48. South America Cell Therapy CDMO Market Size Market Share by Country in 2024
Figure 49. Brazil Cell Therapy CDMO Market Size and Growth Rate (2020-2025) & (M USD)
Figure 50. Argentina Cell Therapy CDMO Market Size and Growth Rate (2020-2025) & (M USD)
Figure 51. Columbia Cell Therapy CDMO Market Size and Growth Rate (2020-2025) & (M USD)
Figure 52. Middle East and Africa Cell Therapy CDMO Market Size and Growth Rate (M USD)
Figure 53. Middle East and Africa Cell Therapy CDMO Market Size Market Share by Region in 2024
Figure 54. Saudi Arabia Cell Therapy CDMO Market Size and Growth Rate (2020-2025) & (M USD)
Figure 55. UAE Cell Therapy CDMO Market Size and Growth Rate (2020-2025) & (M USD)
Figure 56. Egypt Cell Therapy CDMO Market Size and Growth Rate (2020-2025) & (M USD)
Figure 57. Nigeria Cell Therapy CDMO Market Size and Growth Rate (2020-2025) & (M USD)
Figure 58. South Africa Cell Therapy CDMO Market Size and Growth Rate (2020-2025) & (M USD)
Figure 59. Global Cell Therapy CDMO Market Size Forecast by Value (2020-2035) & (M USD)
Figure 60. Global Cell Therapy CDMO Market Share Forecast by Type (2026-2035)
Figure 61. Global Cell Therapy CDMO Market Share Forecast by Application (2026-2035)
Figure 1. Industry Chain of Cell Therapy CDMO
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Cell Therapy CDMO Market Size (M USD), 2025-2035
Figure 5. Global Cell Therapy CDMO Market Size (M USD) (2020-2035)
Figure 6. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 8. Evaluation Matrix of Regional Market Development Potential
Figure 9. Cell Therapy CDMO Market Size by Country (M USD)
Figure 10. Company Assessment Quadrant
Figure 11. Global Cell Therapy CDMO Product Life Cycle
Figure 12. Global Cell Therapy CDMO Revenue Share by Company in 2025
Figure 13. Cell Therapy CDMO Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2025
Figure 14. The Global 5 and 10 Largest Players: Market Share by Cell Therapy CDMO Revenue in 2025
Figure 15. Value Chain Map of Cell Therapy CDMO
Figure 16. Global Cell Therapy CDMO Market PEST Analysis
Figure 17. Global Cell Therapy CDMO Market Porter's Five Forces Analysis
Figure 18. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 19. Global Cell Therapy CDMO Market Share by Type
Figure 20. Market Share of Cell Therapy CDMO by Type (2020-2025)
Figure 21. Global Cell Therapy CDMO Market Size Growth Rate by Type (2021-2025)
Figure 22. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 23. Global Cell Therapy CDMO Market Share by Application
Figure 24. Global Cell Therapy CDMO Market Share by Application (2020-2025)
Figure 25. Global Cell Therapy CDMO Market Share by Application in 2024
Figure 26. Global Cell Therapy CDMO Market Size Growth Rate by Application (2021-2025)
Figure 27. Global Cell Therapy CDMO Market Size Market Share by Region (2020-2025)
Figure 28. North America Cell Therapy CDMO Market Size and Growth Rate (2020-2025) & (M USD)
Figure 29. North America Cell Therapy CDMO Market Size Market Share by Country in 2024
Figure 30. U.S. Cell Therapy CDMO Market Size and Growth Rate (2020-2025) & (M USD)
Figure 31. Canada Cell Therapy CDMO Market Size (M USD) and Growth Rate (2020-2025)
Figure 32. Mexico Cell Therapy CDMO Market Size (M USD) and Growth Rate (2020-2025)
Figure 33. Europe Cell Therapy CDMO Market Size and Growth Rate (2020-2025) & (M USD)
Figure 34. Europe Cell Therapy CDMO Market Share by Country in 2024
Figure 35. Germany Cell Therapy CDMO Market Size and Growth Rate (2020-2025) & (M USD)
Figure 36. France Cell Therapy CDMO Market Size and Growth Rate (2020-2025) & (M USD)
Figure 37. U.K. Cell Therapy CDMO Market Size and Growth Rate (2020-2025) & (M USD)
Figure 38. Italy Cell Therapy CDMO Market Size and Growth Rate (2020-2025) & (M USD)
Figure 39. Spain Cell Therapy CDMO Market Size and Growth Rate (2020-2025) & (M USD)
Figure 40. Asia Pacific Cell Therapy CDMO Market Size and Growth Rate (M USD)
Figure 41. Asia Pacific Cell Therapy CDMO Market Size Market Share by Region in 2024
Figure 42. China Cell Therapy CDMO Market Size and Growth Rate (2020-2025) & (M USD)
Figure 43. Japan Cell Therapy CDMO Market Size and Growth Rate (2020-2025) & (M USD)
Figure 44. South Korea Cell Therapy CDMO Market Size and Growth Rate (2020-2025) & (M USD)
Figure 45. India Cell Therapy CDMO Market Size and Growth Rate (2020-2025) & (M USD)
Figure 46. Southeast Asia Cell Therapy CDMO Market Size and Growth Rate (2020-2025) & (M USD)
Figure 47. South America Cell Therapy CDMO Market Size and Growth Rate (M USD)
Figure 48. South America Cell Therapy CDMO Market Size Market Share by Country in 2024
Figure 49. Brazil Cell Therapy CDMO Market Size and Growth Rate (2020-2025) & (M USD)
Figure 50. Argentina Cell Therapy CDMO Market Size and Growth Rate (2020-2025) & (M USD)
Figure 51. Columbia Cell Therapy CDMO Market Size and Growth Rate (2020-2025) & (M USD)
Figure 52. Middle East and Africa Cell Therapy CDMO Market Size and Growth Rate (M USD)
Figure 53. Middle East and Africa Cell Therapy CDMO Market Size Market Share by Region in 2024
Figure 54. Saudi Arabia Cell Therapy CDMO Market Size and Growth Rate (2020-2025) & (M USD)
Figure 55. UAE Cell Therapy CDMO Market Size and Growth Rate (2020-2025) & (M USD)
Figure 56. Egypt Cell Therapy CDMO Market Size and Growth Rate (2020-2025) & (M USD)
Figure 57. Nigeria Cell Therapy CDMO Market Size and Growth Rate (2020-2025) & (M USD)
Figure 58. South Africa Cell Therapy CDMO Market Size and Growth Rate (2020-2025) & (M USD)
Figure 59. Global Cell Therapy CDMO Market Size Forecast by Value (2020-2035) & (M USD)
Figure 60. Global Cell Therapy CDMO Market Share Forecast by Type (2026-2035)
Figure 61. Global Cell Therapy CDMO Market Share Forecast by Application (2026-2035)
